Ultralife (ULBI) Long-Term Deferred Tax (2014 - 2026)

Ultralife has reported Long-Term Deferred Tax for 13 years, with the latest figure at $10.8 million in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Deferred Tax rose 34.23% year-over-year to $10.8 million; the trailing twelve-month figure through Mar 2026 stood at $10.8 million (up 34.23% YoY), and the FY2025 full-year result was $10.5 million, up 24.74% from the prior year.
• Long-Term Deferred Tax for Q1 2026 stood at $10.8 million, up from $10.5 million in the prior quarter.
• The five-year high for Long-Term Deferred Tax was $13.0 million in Q1 2023, with the low at $7.7 million in Q2 2025.
• Average Long-Term Deferred Tax over 5 years is $10.3 million, with a median of $10.6 million recorded in 2023.
• Year-over-year, Long-Term Deferred Tax retreated 23.85% in 2024 and jumped 34.23% in 2026.
• Tracing ULBI's Long-Term Deferred Tax over 5 years: stood at $12.1 million in 2022, then decreased by 12.45% to $10.6 million in 2023, then retreated by 20.38% to $8.4 million in 2024, then grew by 24.74% to $10.5 million in 2025, then rose by 2.58% to $10.8 million in 2026.
• The last three Long-Term Deferred Tax figures came in at $10.8 million (Q1 2026), $10.5 million (Q4 2025), and $8.2 million (Q3 2025), per Business Quant data.

Peer Comparison